SUZETTE WHILBY: Open Payments
NPI 1194361782 · DOUGLASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 29 payments from 12 companies in 2025. Trend: 2023 $327 · 2024 $615 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $94 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $90 |
| PFIZER INC. | 3 | $68 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Exact Sciences Corporation | 4 | $56 |
| SANOFI-AVENTIS U.S. LLC | 3 | $54 |
| Abbott Laboratories | 2 | $45 |
| Amgen Inc. | 2 | $29 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
Products named: JARDIANCE, Cologuard Collection Kit, TZIELD, FREESTYLE LIBRE 3, PREVNAR 20, ELIQUIS, FARXIGA, TRELEGY ELLIPTA.
Industry payments across GA — which companies pay providers there.
